RSA - ACTIS Hip Stem
Primary Purpose
Hip Osteoarthritis
Status
Active
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
ACTIS
Sponsored by
About this trial
This is an interventional other trial for Hip Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty
- Aged 21 years or older
- Patients willing and able to comply with follow-up requirements and self-evaluations
- Ability to give informed consent
- Body mass index ≤45 kg/m2
Exclusion Criteria
- Active or prior infection
- Medical condition precluding major surgery
- Medical condition with less than 2 years life expectancy
- Overhanging pannus (for anterior approach cohort only)
- Prior surgery of the hip involving implantation of hardware (i.e., hemiarthroplasty, internal fixation, pelvic reconstruction near the acetabulum requiring removal)
- Skin condition on the area of incision
- Multi-level lumbar spine fusion
- Ankylosing spondylolithesis
- Shortening osteotomy through the femur
Sites / Locations
- Orthopaedic Innovation Centre
- Nova Scotia Health - Orthopedic
- London Health Sciences Centre
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
ACTIS hip stem
Arm Description
All participants will receive the ACTIS hip stem.
Outcomes
Primary Outcome Measures
Subsidence of the ACTIS femoral stem
Compare mean 2-year subsidence using model-based RSA (radiostereometric analysis) (mm). The images taken at each time point will be compared with the baseline to assess the change in implant position.
Secondary Outcome Measures
Comparison of migration per surgical approach
Comparison between the 3 approaches (postero-lateral, direct lateral, and direct anterior); measured migration (mm). The images taken at each time point will be compared with the baseline to assess implant migration. Therefore the outcome is change in implant position measured using RSA.
Oxford Hip Score (OHS)
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Evaluate and compare the change from preoperative to 2 years between the study groups and timepoints. The scores in each section (pain, stiffness and function limitation) are totaled; 5 items for pain (score range 0-20), 2 for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
European Quality of Life (EQ-5D-5L) questionnaire
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. A health state score is obtained based on the responses from 1-5 in each subscale, from which a single index value is calculated representing patients' overall health state. The overall health state range from 0 to 1.0.
Visual analogue scale (VAS) for thigh pain
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable).
Visual analogue scale (VAS) for satisfaction
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied).
University of California at Los Angeles (UCLA) Activity Level scale
Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.
Full Information
NCT ID
NCT04879732
First Posted
April 30, 2021
Last Updated
June 26, 2023
Sponsor
Canadian Radiostereometric Analysis Network
Collaborators
DePuy Synthes
1. Study Identification
Unique Protocol Identification Number
NCT04879732
Brief Title
RSA - ACTIS Hip Stem
Official Title
Roentgen Stereophotogrammetric Analysis (RSA): ACTIS Hip Stem
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 5, 2021 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Canadian Radiostereometric Analysis Network
Collaborators
DePuy Synthes
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The principal objective of this study is to compare mean 2-year subsidence of the ACTIS femoral stem using model-based RSA against published migration patterns for hip stems of a similar design. Secondary objectives include comparison of migration per surgical approach, quantifying changes in functional and health status of subjects following surgery, and assess occurrences of complications and adverse events.
Detailed Description
This is a multi-centre, sequential enrollment trial of patients undergoing primary total hip arthroplasty. Patients will be recruited at three Canadian Centres to receive the ACTIS femoral hip stem via 3 different surgical approaches.
Model-based RSA will identify migration of the implant with respect to the femoral bone during the first 2 post-operative years. Patient health and functional outcomes will be recorded at pre- and post-operative intervals to quantify improvement as a result of the surgery and trajectory of recovery. Adverse events and clinical complications in each study group will be captured and compared. Select surgical, hospital and rehabilitation data will be collected to measure health economic outcomes relating to the surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Osteoarthritis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ACTIS hip stem
Arm Type
Other
Arm Description
All participants will receive the ACTIS hip stem.
Intervention Type
Device
Intervention Name(s)
ACTIS
Intervention Description
ACTIS Hip stem
Primary Outcome Measure Information:
Title
Subsidence of the ACTIS femoral stem
Description
Compare mean 2-year subsidence using model-based RSA (radiostereometric analysis) (mm). The images taken at each time point will be compared with the baseline to assess the change in implant position.
Time Frame
2 Year
Secondary Outcome Measure Information:
Title
Comparison of migration per surgical approach
Description
Comparison between the 3 approaches (postero-lateral, direct lateral, and direct anterior); measured migration (mm). The images taken at each time point will be compared with the baseline to assess implant migration. Therefore the outcome is change in implant position measured using RSA.
Time Frame
2 Year
Title
Oxford Hip Score (OHS)
Description
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance.
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Title
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Description
Evaluate and compare the change from preoperative to 2 years between the study groups and timepoints. The scores in each section (pain, stiffness and function limitation) are totaled; 5 items for pain (score range 0-20), 2 for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Title
European Quality of Life (EQ-5D-5L) questionnaire
Description
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments, patient reported outcome. A health state score is obtained based on the responses from 1-5 in each subscale, from which a single index value is calculated representing patients' overall health state. The overall health state range from 0 to 1.0.
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Title
Visual analogue scale (VAS) for thigh pain
Description
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable).
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Title
Visual analogue scale (VAS) for satisfaction
Description
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied).
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
Title
University of California at Los Angeles (UCLA) Activity Level scale
Description
Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.
Time Frame
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year and 2 Years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty
Aged 21 years or older
Patients willing and able to comply with follow-up requirements and self-evaluations
Ability to give informed consent
Body mass index ≤45 kg/m2
Exclusion Criteria
Active or prior infection
Medical condition precluding major surgery
Medical condition with less than 2 years life expectancy
Overhanging pannus (for anterior approach cohort only)
Prior surgery of the hip involving implantation of hardware (i.e., hemiarthroplasty, internal fixation, pelvic reconstruction near the acetabulum requiring removal)
Skin condition on the area of incision
Multi-level lumbar spine fusion
Ankylosing spondylolithesis
Shortening osteotomy through the femur
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Turgeon, MD
Organizational Affiliation
University of Manitoba
Official's Role
Principal Investigator
Facility Information:
Facility Name
Orthopaedic Innovation Centre
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R2K 2M9
Country
Canada
Facility Name
Nova Scotia Health - Orthopedic
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2E1
Country
Canada
Facility Name
London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
RSA - ACTIS Hip Stem
We'll reach out to this number within 24 hrs